Wireless smart contact lens for diabetic diagnosis and therapy.
Do Hee KeumSu-Kyoung KimJahyun KooGeon-Hui LeeCheonhoo JeonJee Won MokBeom Ho MunKeon Jae LeeEhsan KamraniChoun-Ki JooSangbaie ShinJae-Yoon SimDavid MyungSeok Hyun YunZhenan BaoSei Kwang HahnPublished in: Science advances (2020)
A smart contact lens can be used as an excellent interface between the human body and an electronic device for wearable healthcare applications. Despite wide investigations of smart contact lenses for diagnostic applications, there has been no report on electrically controlled drug delivery in combination with real-time biometric analysis. Here, we developed smart contact lenses for both continuous glucose monitoring and treatment of diabetic retinopathy. The smart contact lens device, built on a biocompatible polymer, contains ultrathin, flexible electrical circuits and a microcontroller chip for real-time electrochemical biosensing, on-demand controlled drug delivery, wireless power management, and data communication. In diabetic rabbit models, we could measure tear glucose levels to be validated by the conventional invasive blood glucose tests and trigger drugs to be released from reservoirs for treating diabetic retinopathy. Together, we successfully demonstrated the feasibility of smart contact lenses for noninvasive and continuous diabetic diagnosis and diabetic retinopathy therapy.
Keyphrases
- diabetic retinopathy
- blood glucose
- drug delivery
- optical coherence tomography
- healthcare
- type diabetes
- cataract surgery
- wound healing
- endothelial cells
- gold nanoparticles
- blood pressure
- metabolic syndrome
- ionic liquid
- machine learning
- electronic health record
- high throughput
- stem cells
- mesenchymal stem cells
- mass spectrometry
- adipose tissue
- glycemic control
- heart rate
- replacement therapy
- big data
- insulin resistance
- combination therapy
- artificial intelligence
- deep learning
- weight loss
- data analysis
- affordable care act